Prosecution Insights
Last updated: May 04, 2026
Application No. 17/078,607

CRANIAL PLUG INCLUDING AN INTRACRANIAL MONITORING DEVICE

Final Rejection §102
Filed
Oct 23, 2020
Priority
Oct 24, 2019 — provisional 62/925,428
Examiner
TU, AURELIE H
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Longeviti Neuro Solutions Inc.
OA Round
8 (Final)
56%
Grant Probability
Moderate
9-10
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allowance Rate
126 granted / 227 resolved
-14.5% vs TC avg
Strong +62% interview lift
Without
With
+62.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
66 currently pending
Career history
293
Total Applications
across all art units

Statute-Specific Performance

§101
20.8%
-19.2% vs TC avg
§103
31.1%
-8.9% vs TC avg
§102
15.6%
-24.4% vs TC avg
§112
28.2%
-11.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 227 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment Claims 1, 2, 5, 9-17 are currently pending. Claims 9-17 remain withdrawn. Claim 1 has been amended. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 2, and 5 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Flitter (“Techniques of Intracranial Pressure Monitoring” – 1981). Regarding claim 1, Flitter teaches a cranial plug assembly (Fig. 31.7), comprising: an intracranial monitoring device (Fig. 31.7 (A)) including a head and a probe extending from the head (see annotated Fig. 31.7), the head includes a housing in which electronic components are housed and the probe extends from the housing of the head (The caption states that (A) has a pressure transducer and telemetry packages, indicating electronic components are included.); and a cranial plug housing separate and distinct from the intracranial monitoring device (Fig. 31.7 (B) and (C)), the cranial plug housing including a first end, a second end, a first lateral side, a second lateral side, an upper surface, a lower surface, and a recessed surface defining an intracranial monitoring device recess formed along the upper surface of the cranial plug housing (see annotated Fig. 31.7), the intracranial monitoring device recess comprises a recessed surface formed along the upper surface of the cranial plug housing, the recessed surface comprises a cylindrical interior wall extending downwardly from the upper surface (The inside of (B) is a cylindrical interior) and a base wall, wherein the base wall defines a ledge upon which the intracranial monitoring device sits when positioned within the intracranial monitoring device recess (The bottom of the recessed surface includes a ledge, as seen in Fig. 31.7.), the intracranial monitoring device recess is shaped and dimensioned for positioning of the head of the intracranial monitoring device therein and the intracranial monitoring device recess is provided with a central access hole extending from the intracranial monitoring device recess to the lower surface of the cranial plug housing ((A) is inserted into (B) and (C), as seen in Fig. 31.7.), wherein the probe is selectively passed through the central access hole to a desired position within the brain when the head of the intracranial monitoring device is positioned within the intracranial monitoring device recess (The probe of (A) is passed through the central access hole to be positioned near the brain.). PNG media_image1.png 566 738 media_image1.png Greyscale Regarding claim 2, Flitter teaches wherein the intracranial monitoring device is a wireless intracranial monitoring device (Pages 556-557; “The device does require a radio frequency antenna positioned on the scalp overlying the transducer for purposes of energizing the implanted portion of the system. The readout module may be several meters distant from the patient.”). Regarding claim 5, Flitter teaches wherein the lower surface is provided with a projection shaped and dimensioned to fit within a cranial hole (Fig. 31.7 shows that the lower surface has a projection shape and fits within a cranial hole.). Response to Arguments Applicant’s arguments with respect to claims 1, 2, and 5 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to AURELIE H TU whose telephone number is (571)272-8465. The examiner can normally be reached [M-F] 7:30-3:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alexander Valvis can be reached at (571) 272-4233. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AURELIE H TU/ Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Show 17 earlier events
Jun 03, 2025
Response Filed
Jul 08, 2025
Final Rejection — §102
Oct 08, 2025
Notice of Allowance
Oct 08, 2025
Response after Non-Final Action
Oct 28, 2025
Response after Non-Final Action
Nov 17, 2025
Non-Final Rejection — §102
Feb 09, 2026
Response Filed
Mar 16, 2026
Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12611112
Devices and Methods for Controlling Inflation Rate in Blood Pressure Measurements
3y 3m to grant Granted Apr 28, 2026
Patent 12605081
CUFF FOR BLOOD PRESSURE MEASUREMENT, AND METHOD OF MANUFACTURING CUFF FOR BLOOD PRESSURE MEASUREMENT
4y 8m to grant Granted Apr 21, 2026
Patent 12593995
A BLOOD PRESSURE MEASURING DEVICE
3y 2m to grant Granted Apr 07, 2026
Patent 12593992
SPHYGMOMANOMETER, PERSONAL AUTHENTICATION METHOD ON A SPHYGMOMANOMETER, AND COMPUTER-READABLE RECORDING MEDIUM
2y 11m to grant Granted Apr 07, 2026
Patent 12591305
INTELLIGENT HUMAN-MACHINE INTERFACE AND METHOD WHICH CAN BE CARRIED OUT USING SAME
2y 10m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

9-10
Expected OA Rounds
56%
Grant Probability
99%
With Interview (+62.0%)
3y 7m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 227 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month